Mandate

Vinge represents ADB BVBA in connection with the acquisition of Safegate

February 26, 2016

Vinge, together with Willkie Farr & Gallagher, represents ADB BVBA, a portfolio company to the French private equity fund PAI Partners, in its acquisition of Safegate from Fairford. Together they will form the new ADB Safegate group.

Safegate is a leading airfield solutions business providing aircraft docking guidance systems, gate management systems, airfield lighting solutions and air traffic control systems to more than 1,300 airports in 130 countries. Safegate is headquartered in Malmö, Sweden, has more than 300 employees worldwide and generated revenue of SEK 1.3 billion in 2015. The ADB Group comprises ADB Airfield Solutions, LUCEBIT and ERNI AGL, three world-leading airfield technology companies specializing in end-to-end, integrated and sustainable solutions for visual guidance. The ADB Group has a worldwide presence and experience spanning 69 years in airfield lighting. More than 2000 airports in 175 countries have chosen ADB as their preferred partner for airside operations.

Vinge’s team primarily consisted of Jonas Bergström, Maria Dahlin, Ulrich Ziche, Samra Baytar, Manne Bergström, Linn Adelwald, Adam Sandberg, Maria Schultzberg, Jasmin Draszka-Ali, Carl Sander, Isabell Nielsen and Lova Unge.

Related

Vinge advises Trianon in connection with directed share issue and tender offer for subordinated sustainable capital securities

Vinge advises Fastighets Aktiebolaget Trianon (publ) in connection with a directed share issue of SEK 184 million and a tender offer for outstanding subordinated perpetual floating rate callable sustainable capital securities.
April 19, 2024

Vinge advises Blackstone in connection with its investment in Winthrop Technologies

Vinge, as local Swedish counsel, advised Blackstone Tactical Opportunities and affiliated funds (“Blackstone”) in connection with a strategic partnership with Winthrop Technologies Limited (“Winthrop Technologies”).
April 17, 2024

Vinge has advised Hansa Biopharma in connection with a directed share issue of SEK 372 million

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue through which the company raises proceeds of SEK 372 million before transaction costs. Hansa Biopharma is a commercial-stage biopharmaceutical company pioneering the development and commercialization of innovative, lifesaving and life altering treatments for patients with rare immunological conditions. Hansa Biopharma’s ordinary share is listed on Nasdaq Stockholm.
April 16, 2024